Holen Sie sich die Stockscreener-App
20.50
0.44%
0.09
Handel nachbörslich:
20.75
0.25
+1.22%
Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten
[144] Zai Lab Ltd SEC Filing - stocktitan.net
ZLAB (NASDAQ: ZLAB) Form 144 shows Rafael Amado sold ADS in Mar–Apr 2026 - stocktitan.net
ZLAB (NASDAQ: ZLAB) notices proposed sale of 853 ADS; prior transfers listed - stocktitan.net
Yajing Chen Sells 5,199 Shares of Zai Lab (NASDAQ:ZLAB) Stock - defenseworld.net
Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer - BioPharma APAC
Zai Lab Limited (9688.HK) stock price, news, quote and history - Yahoo Finance Singapore
Zai Lab Limited (ZLAB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zai Lab Limited (ZLAB) stock price, news, quote and history - Yahoo Finance UK
Revenue per share of Zai Lab Ltd. Sponsored ADR – FWB:1ZL - TradingView
Zai Lab (NASDAQ:ZLAB) CFO Sells $106,007.61 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Sells $196,029.46 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) CEO Ying Du Sells 5,576 Shares - marketbeat.com
Rafael Amado Sells 9,910 Shares of Zai Lab (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab (ZLAB) executive sells ADSs to cover tax after RSU vest - stocktitan.net
Zai Lab Ltd (ADR) stock: China's biotech powerhouse eyes global gains - AD HOC NEWS
Zai Lab (ZLAB) CLO nets ADSs after RSU vesting and tax sale - stocktitan.net
Rafael Amado reports ADS sales for ZLAB (NASDAQ: ZLAB) - Stock Titan
9,614 ADS tied to vesting listed by ZLAB (NASDAQ: ZLAB) with Fidelity broker - stocktitan.net
Insider sells ZLAB (NASDAQ: ZLAB) ADS — Form 144 lists 4,194 shares - stocktitan.net
Affiliate sale notice: ZLAB (NASDAQ: ZLAB) up to 5,199 ADS - stocktitan.net
Zai Lab (NASDAQ:ZLAB) Trading 9.5% HigherStill a Buy? - marketbeat.com
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy - ChartMill
KeyCorp (NYSE:KEY) Price Target Cut to $24.00 by Analysts at Morgan Stanley - Defense World
Hesai Group Sponsored ADR (NASDAQ:HSAI) Given Consensus Rating of “Buy” by Brokerages - Defense World
Hennes & Mauritz AB (OTCMKTS:HNNMY) Given Average Recommendation of “Hold” by Brokerages - Defense World
HBT Financial, Inc. (NASDAQ:HBT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Rating of “Hold” by Analysts - Defense World
NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
BTC Capital Management Inc. Lowers Holdings in Verizon Communications Inc. $VZ - Defense World
Constellation Software Inc. (OTCMKTS:CNSWF) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
The Goldman Sachs Group Issues Positive Forecast for Bicara Therapeutics (NASDAQ:BCAX) Stock Price - Defense World
KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Precision Drilling Corporation (NYSE:PDS) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Kraken Robotics Inc. (CVE:PNG) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Sees Large Growth in Short Interest - marketbeat.com
Zai Lab (NASDAQ:ZLAB) Shares Gap UpShould You Buy? - MarketBeat
Zai Lab (09688.HK) Narrows Loss to USD176 Million Last Year - AASTOCKS.com
Virtus Biotech ETF Holdings - Quiver Quantitative
Richard Gaynor Acquires 1,731 Shares of Zai Lab (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab (ZLAB) director adds 1,731 ADS in Rule 10b5-1 purchase - Stock Titan
Zai Lab (NASDAQ:ZLAB) Given New $32.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC) - ChartMill
Zai Lab (NASDAQ:ZLAB) CFO Sells $31,726.89 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Joshua Smiley Sells 1,966 Shares - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Sells $55,088.91 in Stock - MarketBeat
Zai Lab (ZLAB) officer granted options, RSUs and sells ADSs for taxes - Stock Titan
Zai Lab (ZLAB) CLO awarded major option, RSU grants and sells ADSs for taxes - Stock Titan
Zai Lab (NASDAQ: ZLAB) officer gets major equity grants, sells ADSs for taxes - Stock Titan
Zai Lab (ZLAB) CEO receives large ADS option and RSU grants - Stock Titan
Assessing Zai Lab (ZLAB) Valuation After Prolonged Share Price Weakness And Reported Intrinsic Discount - Sahm
ZLAB (NASDAQ: ZLAB) notice: 1,281 ADS proposed sale on 03/13/2026 - Stock Titan
Rafael Amado sells ZLAB ADS; 10,787 and 10,000 shares reported (ZLAB) - Stock Titan
Zai Lab Ltd (ADR) Stock (ISIN: CA98959U1084) Faces Insider Selling Pressure Amid Earnings Anticipati - AD HOC NEWS
[Form 4] Zai Lab Ltd Insider Trading Activity - Stock Titan
Zai Lab (NASDAQ: ZLAB) director files Form 144 to sell ADS - stocktitan.net
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):